LimFlow Vector
FDA 510(k) K260188 · LimFlow, Inc.
510(k) numberK260188
Submission
- Device name
- LimFlow Vector
- Applicant
- LimFlow, Inc.
Irvine, CA, US - Received
- January 22, 2026
- Decision date
- March 18, 2026
- Decision
- Substantially Equivalent (SESE)
- Type
- Special 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MGZ – Valvulotome
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 870.4885
- Specialty
- Cardiovascular
Other 510(k)s with product code MGZ
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K250105 | Boomerang Valvulotome (BMGVT080); Boomerang Push Valvulotome (BMGPVT125)MGZ · Traditional | Aveera Medical, Inc. | 07/03/2025SE |
| K221902 | LimFlow VectorMGZ · Traditional | LimFlow, Inc. | 12/21/2022SE |
| K190267 | EZE SIT ValvulotomeMGZ · Traditional | Lemaitre Vascular | 10/30/2019SE |
| K142660 | Antegrade LeMills ValvulotomeMGZ · Special | LeMaitre Vascular, Inc. | 10/17/2014SE |
| K140042 | 1.5MM Hydro Expandable Lemaitre ValvulotomeMGZ · Traditional | LeMaitre Vascular, Inc. | 04/10/2014SE |
| K132047 | Lemills ValvulotomeMGZ · Traditional | LeMaitre Vascular, Inc. | 11/05/2013SE |
| K132190 | Expandable Lemaitre Valvulotome, Over-The-Wire Lemaitre ValvulotomeMGZ · Traditional | LeMaitre Vascular, Inc. | 08/05/2013SE |
| K111884 | Over-The-Wire Expandable Lemaitre ValvulotomeMGZ · Special | LeMaitre Vascular, Inc. | 07/29/2011SE |
| K080178 | Valvulotome by KovenMGZ · Traditional | Koven Technology, Inc. | 07/28/2008SE |
| K022823 | Valvulotome, Retrograde : 03-7500- 03-7510, Antegrade 03-7520MGZ · Traditional | Geister Medizin Technik GmbH | 07/01/2004SE |
More from Geister Medizin Technik GmbH
Questions and answers
When was LimFlow Vector cleared by the FDA?
LimFlow Vector (K260188) received a 510(k) decision of Substantially Equivalent on March 18, 2026, 55 days after the submission was received.
What is the product code of K260188?
The FDA product code is MGZ – Valvulotome, a Class II (moderate risk) device regulated under 21 CFR 870.4885.